Your session is about to expire
← Back to Search
Surgery for Spinal Stenosis
N/A
Waitlist Available
Led By Steven Passmore, DC, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Confirmed clinical diagnosis of lumbar spinal stenosis through diagnostic imaging and clinical testing/history from a spine surgeon
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline activity measures at 6 weeks (post-surgery or post non-intervention)
Awards & highlights
Study Summary
This trial will explore whether surgery for lumbar spinal stenosis leads to increased physical activity. A control group will be measured for comparison.
Who is the study for?
This trial is for individuals who have been clinically diagnosed with lumbar spinal stenosis (LSS) and confirmed to need surgery by a spine surgeon. Participants should be pre-surgical but require the operation as determined through diagnostic imaging and clinical history.Check my eligibility
What is being tested?
The study aims to determine if surgical intervention for LSS leads to increased physical activity post-surgery. It involves comparing the activity levels of patients before and after surgery, against a control group not undergoing surgery.See study design
What are the potential side effects?
While specific side effects are not detailed in this summary, typical risks associated with surgical interventions may include pain at the incision site, infection, bleeding, or complications related to anesthesia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with lumbar spinal stenosis by a spine surgeon.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline activity measures at 6 weeks (post-surgery or post non-intervention)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline activity measures at 6 weeks (post-surgery or post non-intervention)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Activity Measure - Maximum Bout Length
Activity Measure - Maximum Continuous Daily Activity
Activity Measure - Rate
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Surgical Intervention GroupExperimental Treatment1 Intervention
The Surgical Intervention Group will undergo the routine surgical procedures taken for patients requiring surgery for degenerative lumbar spinal stenosis.
Group II: Non-Intervention Group (Control)Active Control1 Intervention
No Intervention.This group will consist of patients wait listed for surgery but further back in the queue.
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,457 Total Patients Enrolled
2 Trials studying Spinal Stenosis
74 Patients Enrolled for Spinal Stenosis
Gibson Orthopaedic Fund for Research and EducationOTHER
2 Previous Clinical Trials
271 Total Patients Enrolled
1 Trials studying Spinal Stenosis
24 Patients Enrolled for Spinal Stenosis
Steven Passmore, DC, PhDPrincipal InvestigatorUniversity of Manitoba
1 Previous Clinical Trials
24 Total Patients Enrolled
1 Trials studying Spinal Stenosis
24 Patients Enrolled for Spinal Stenosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have not been diagnosed with narrowing of the spinal canal in my lower back.I have been diagnosed with lumbar spinal stenosis by a spine surgeon.I do not require immediate surgery.I need surgery as confirmed by a spine surgeon.
Research Study Groups:
This trial has the following groups:- Group 1: Surgical Intervention Group
- Group 2: Non-Intervention Group (Control)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are people aged 45 years or older allowed to participate in this experiment?
"The age group that this study is targeting are individuals who are at least 18 years old, but not yet 80."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger